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ABSTRACT
Introduction: Co-infection of TB/HIV is currently a serious health threat to the world population. Efforts to 
control tuberculosis and HIV programs still facing obstacles, especially if the two diseases allied, it will be 
more difficult and challenging for both prevention program. Both TB and HIV have higher burden disease and 
need to be cope urgently. Adequate treatment of TB in co-infected patients can reduce the high morbidity 
and mortality of patients, prevent treatment failure and improve the success rate.
Objectives: Determine the proportion of successful treatment of TB among HIV-TB patients in H. Adam 
Malik General Hospital between 2011-2013 and identified the factors that influenced the success of their 
TB treatment.
Methods: A case control study design using medical records of HIV-TB patients in VCT polyclinic of H. Adam 
Malik General Hospital from 2011-2013.
Results: The average success rate of TB treatment among HIV-TB patients in H. Adam Malik General Hospital 
was 68.56%. Male, age ≤40 years, pulmonary TB, CD4 count <200, anemia, HIV stage 3 and adherence to 
TB treatment dominated this research, (60,82%, 76,29%, 71,13%, 74,23%, 60,82%, 55,15% and 53,09% 
respectively). Gender (aOR 3.87 95% CI: 1.21 - 18.31), CD4 101-200 (aOR 5.06 95% CI: 1.06 - 24.04), CD4> 
200 (aOR 15, 80 95% CI: 3.18 - 78.64), status of anemia (aOR 2.00 95% CI: 1.22 - 3.26) and adherence to TB 
treatment (aOR 6.16 95% CI: 2.07 - 18.31) were statistically significant in multivariate analysis. Other factors 
such as age, classification of TB disease and HIV stage were not significant (p values> 0.05). 
Conclusion: Female, CD4 cell counts 101-200, CD4 count> 200, status of anemia and adherence to TB 
treatment determined the successful of TB treatment among HIV-TB patients. Implementation of TB/HIV 
collaborative program and DOTS strategy in TB treatment increases the success rate of TB treatment among 
HIV-TB patients at H. Adam Malik General Hospital.
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INTISARI
Pendahuluan: Ko-infeksi TB/HIV saat ini menjadi ancaman kesehatan serius bagi penduduk dunia. Upaya 
penanggulangan program TB maupun HIV selama ini masih menghadapi kendala apalagi jika kedua penyakit 
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tersebut bersekutu akan lebih menyulitkan dan menjadi tantangan bagi penanggulangan kedua program. Baik 
TB maupun HIV, keduanya mempunyai burden disease yang cukup tinggi untuk segera ditangani. Pengobatan 
TB yang adekuat pada pasien koinfeksi dapat menekan tingginya angka morbiditas dan mortalitas pasien, 
mencegah kegagalan terapi serta meningkatkan angka keberhasilan.
Tujuan: Mengetahui proporsi keberhasilan pengobatan TB pada penderita HIV di RSUP H. Adam Malik Medan 
tahun 2011-2013 serta mengidentifikasi faktor-faktor yang mempengaruhi keberhasilan pengobatan TB-nya.
Metode: Desain penelitian yang digunakan adalah case control, menggunakan data sekunder Poliklinik VCT 
Pusyansus RSUP H. Adam Malik Medan 2011-2013. 
Hasil: Rata-rata keberhasilan pengobatan TB pada penderita HIV di RSUP H. Adam Malik Medan tahun 
2011-2013 sebesar 68,56%. Jenis kelamin laki-laki, umur ≤40 tahun, lesi TB di paru, jumlah CD4 <200, 
status anemia, stadium 3 HIV dan keteraturan pengobatan OAT mendominasi penelitian ini, masing-masing 
sebesar 60,82%, 76,29%, 71,13%, 74,23%, 60,82%, 55,15% dan 53,09%. Variabel jenis kelamin (aOR 3,87 
95%CI: 1,21 - 18,31), jumlah CD4 101-200 (aOR 5,06 95%CI: 1,06 - 24,04), CD4 >200 (aOR 15,80 95%CI: 
3,18 - 78,64), tidak anemia (aOR 2,00 95%CI: 1,22 - 3,26) dan keteraturan pengobatan TB (aOR 6,16 95%CI: 
2,07 - 18,31) berhubungan signifikan dalam analisis multivariat. Faktor lain yaitu umur, klasifikasi penyakit 
TB dan stadium HIV tidak bermakna (nilai p>0,05).
Simpulan: Jenis kelamin perempuan, jumlah CD4 101-200, jumlah CD4 >200, tidak anemia dan teratur 
menjalani pengobatan OAT menentukan keberhasilan pengobatan TB pada penderita HIV-TB. Implementasi 
program kolaborasi TB/HIV dan penerapan strategi pengobatan TB dengan DOTS meningkatkan angka 
keberhasilan pengobatan TB di RSUP H. Adam Malik Medan.
Kata kunci: keberhasilan, pengobatan tuberkulosis, HIV-TB
INTRODUCTION
World Health Organization (WHO) in 
2000 has launched a program known as the 
Millennium Development Goals (MDGs). The 
MDG program contained 8 main goals to be 
achieved within 15 years as an attempt to 
resolve issues related to human rights, poverty, 
education, health and environment. One of the 
targets to be achieved is the fight against HIV/
AIDS, tuberculosis, malaria and other infectious 
diseases1.
HIV/AIDS epidemic so far has infected 
almost 78 million people and caused 39 million 
deaths2,3,4. In 2014, about 36.9 million people 
were reported to be living with HIV/AIDS4. The 
HIV-infected individuals were vulnerable to 
other opportunistic infections, including TB. 
Tuberculosis was the second most common 
diseases found in people living with HIV (PLWH) 
after oral candidiasis. Along with HIV, both of 
them were the most leading deaths from all 
infectious diseases in the world5,.6. Approximately 
13% or 1.1 million of the 9 million TB patients in 
the world were infected with TB/HIV and about 
360,000 died in 2013 6. In people living with HIV, 
the risk of developing tuberculosis is increased 
5-15% per year compared to immunocompetent 
individuals who only at risk of 5-10% throughout 
their lifetime7.
The number of PLWH in North Sumatra 
province was increasing from year to year. 
Hence, it was not surprising that North Sumatra 
belonged to the top 10 provinces in Indonesia 
which has the highest cumulative cases of AIDS. 
Meanwhile the city of Medan was the main 
contributor of HIV/AIDS cases in North Sumatra 
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throughout 20135,8. Similar trend has been seen 
in the number of HIV-TB cases in Medan. Since 
the TB program has integrated with HIV program 
at H. Adam Malik General Hospital, a total of 
1026 coinfected patients have been getting 
treatment9.
Both TB and HIV have a strong synergistic 
effect that mutually influence each other. HIV 
infection causes the depletion of CD4 cells such 
as lymphocytes, macrophages and monocytes. 
Besides that, the virus altered their function as 
well. These cells are very important in controlling 
the infection against pathogenic microorganisms 
that enter the body including Mycobacterium 
tuberculosis10. The presence of TB will increase 
HIV replication, accelerate the progression of 
the disease thus aggravate the condition of 
patients11,12,13. Meanwhile HIV infection will 
lead to increase proliferation of TB bacteria 
and activate latent TB 14,15,16. Ultimately this will 
increase the risk of transmission and spread of 
the disease, affecting the clinical manifestations 
of TB in PLWH, treatment of patients and the 
outcomes of treatment15,17.
The TB program in HIV patients also apply 
the same strategy with TB patients without HIV. 
Through the DOTS strategy, patients are directly 
supervised by health workers assisted by a 
medication supervisor. This is done to ensure the 
regularity and compliance of the patient during 
treatment18,19. According to WHO, the treatment 
of tuberculosis in HIV patient is given within a 
minimum of 6 months, generally among HIV it 
takes longer, approximately 8-9 months. Some 
cases have even reached 1 year of treatment 
and often the treatment outcome among HIV 
patients tend to be poor9,18.
The enormous problem that arise due to 
both diseases give a challenge for tuberculosis 
and HIV disease control, and it will be more 
dangerous if the disease is allied. Some obstacles 
have been faced in handling coinfected patients 
starting from the detection of cases, diagnosis 
and management of treatment. These coinfected 
patients are more difficult to manage compare 
to individuals who have been infected with only 
one disease. Great effort, well coordination and 
strict supervision from various institution are 
needed in order to maximize the achievement of 
TB/HIV collaborative program. To achieve better 
treatment outcome, it is essential to know how 
well the implementation of TB program among 
HIV has been going which is indicated by the 
success rate of TB and identify the factors that 
influence the success of TB treatment. Hopefully, 
the burden disease of TB among HIV patients 
could be reduced so that the morbidity, mortality 
and treatment failure rate could be lowered thus 
preventing the emergence of MDR-TB cases20,21.
MATERIALS AND METHODS
We conducted a case-control study using 
secondary data of HIV-TB patients in VCT 
polyclinic of H. Adam Malik General Hospital 
from 2011-2013. The inclusion criteria were 
PLWH who was also diagnosed with TB, aged 
> 17 years and followed the DOTS program. 
Meanwhile, the exclusion criteria were pregnant 
women, only one visit, patients referred in 
with incomplete baseline data and patient who 
moved out to other health centre.
We categorized the successful patients as 
a case group while the unsuccessful patients 
were assessed as a control group with a sample 
of 97 patients in each group. The successful 
outcome included patients who were declared 
as cured or have completed TB treatment while 
the patient who failed, default or died were 
classified as unsuccessful. We have collected 
data on patients gender, age, classification of 
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TB disease, CD4 cell count, hemoglobin level, 
stage of HIV, adherence to TB treatment and the 
outcome of TB treatment.
A Stata v.12. was used to process and 
analyze data. At first, the process of editing, 
cleaning, coding, entering and tabulating data 
were done. Then, the data was analyzed using 
univariate analysis, followed by bivariate using 
chi square test and multivariate analysis using 
logistic regression. The variable was statistically 
significant if the Odds Ratio (OR) > 1, the value 
95% Confidence Interval (CI) does not exceed 1 
and the p-value <0.05.
This study has received a permission from 
the ethics committee of Medical Faculty Gadjah 
Mada University and H. Adam Malik General 
Hospital.
RESULTS AND DISCUSSION
The average success rate of TB treatment 
among HIV patients in VCT polyclinic between 
2011-2013 was 68.56% (Figure 1). Since the TB/
HIV collaborative program was implemented at 
VCT polyclinic of H. Adam Malik, the success 
rate of TB treatment among HIV patients has 
increased significantly. Initially the success rate 
was only 56.92% in 2009, then accelerated 
11.29% to 68.21% at the end of 2013. The 
success rate that has been found was lower 
than the success rate of TB treatment among 
HIV negative patients (85%). Nevertheless, it 
has reached an average rate of successful TB 
treatment among HIV patients globally22.
Figure 1.  Success rate of tuberculosis treatment among HIV patients in VCT polyclinic of H. Adam Malik 
General Hospital between 2009-2013.
The proportion of male gender was 60.82%, 
aged ≤40 years (76.29%), TB lesions in the lung 
(71.13%), CD4 count <200 (74.23%), anemia (60, 
82%), stage 3 of HIV (55.15%), and adherence to 
TB treatment (53.09%) (Table 1).
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Table 1.  Basic characteristics of HIV-TB patients in VCT polyclinic of H. Adam Malik General Hospital.
Basic characteristics
Successful 
n = 97 (%)
Unsuccessful 
n = 97 (%)
Total Patients 
n = 194 (%)
Age 
• > 40 years 
• ≤ 40 years
21 (45,65) 
76 (51,35) 
25 (53,33) 
72 (48,65) 
46 (23,71) 
148 (76,29)
Gender 
• Male 
• Female
41 (34,75) 
56 (73,68)
77 (65,25) 
20 (26,32)
118 (60,82) 
76 (39,18)
Classification of TB 
• Extrapulmonal 
• Pulmonal
25 (44,64) 
72 (52,17)
31 (55,36) 
66 (47,83) 
56 (28,87) 
138 (71,13)
CD4 count 
• CD4 <50 
• CD4 50-100 
• CD4 101-200 
• CD4 >200
11 (18,64) 
12 (31,58) 
32 (68,09) 
42 (84,00)
48 (81,36) 
26 (68,42) 
15 (31,91) 
8 (16,00)
59 (30,41) 
38 (19,59) 
47 (24,23) 
50 (25,77)
Status of anemia 
• Anemia 
• Not anemia 
• Unknown
52 (44,07) 
41 (59,42) 
4 (57,14)
66 (55,93) 
28 (40,58) 
3 (42,86) 
118 (60,82) 
69 (35,57) 
7 (3,61)
HIV Stage 
• Stage 4 
• Stage 3 
41 (47,13) 
56 (52,34) 
46 (52,87) 
51 (47,66) 
87 (44,85) 
107 (55,15)
Adherence to TB treatment 
• No 
• Yes 
18 (19,78) 
79 (76,70) 
73 (80,22) 
... (23,30) 
91 (46,91) 
103 (53,09)
From bivariate analysis (Table 2) variables 
on gender, CD4 count 101-200, CD4 count > 200, 
status of anemia and adherence to TB treatment 
were significantly associated with successful 
treatment of TB among coinfected patients . 
Then the variables with the value  of p≤0,25 were 
included to be analyzed in multivariate analysis. 
A multivariate analysis was done to determine 
which factor contributed the most to the success 
of TB treatment among HIV-TB patients. 
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Table 2.  Bivariate and multivariate analysis of factors associated to the success of tuberculosis treatment 
among HIV patients
Bivariate analysis Multivariate analysis
Variables Unadj. OR  95% CI p-value aOR 95% CI p-value
Age 
• > 40 years 
• ≤ 40 years
1.00 
1.26 
- 
0.65 - 2.44 0.500
Gender 
• Male 
• Female 
1.00 
5.26
- 
2.78 - 9.93 <0.001 
1.00 
3.87
- 
1.21 - 12.43 0.023
Classification of TB 
• Extrapulmonal 
• Pulmonary
1.00 
1.35 
- 
0.72 - 2.52 0.342
CD4 count 
• CD4 <50 
• CD4 50-100 
• CD4 101-200 
• CD4 >200
1.00 
2.01 
9.31 
22.91 
- 
0.78 - 5.19 
3.79 - 22.84 
8.42 - 62.30
0.147 
<0.001 
<0.001
1.00 
4.62 
5.06 
5.80 
- 
0.99 - 21.47 
1.06 - 24.04 
3.18 - 78.64
0.051 
0.042 
0.001
Status of anemia 
• Anemia 
• Not anemia
1.00 
1.36 
- 
1.01 - 1.84 0.044
1.00 
2.00
- 
1.22 - 3.26 0.006
HIV stage 
• Stage 4 
• Stage 3 
1.00 
1.23 
- 
0.70 - 2.17 
0.471 
Adherence to TB 
treatment 
• Yes 
• No 
1.00 
13.35
- 
6.70 - 26.59 <0.001
1.00 
6.16
- 
2.07 - 18.31 0.001
*Unadj. OR = unadjusted OR, aOR= adjusted OR
Male gender (aOR 3.87 95% CI: 1.21 - 
18.31), CD4 count 101-200 (aOR 5.06 95% CI: 
1.06 - 24.04), CD4> 200 (aOR 15, 80 95% CI: 
3.18 - 78.64), unanemia (aOR 2.00 95% CI: 1.22 
- 3.26) and adherence to TB treatment (aOR 
6.16 95% CI: 2.07 - 18.31) were significantly 
related to the success of TB treatment after 
being analyzed in multivariate. Of the four 
variables which were significant in multivariate, 
CD4 count> 200 contributed the most to the 
success of TB treatment. Other factors such as 
age, classification of TB disease and HIV stage 
were not significant.
Female patients tend to be 3 times more 
succeed than men (aOR = 3.87 95% CI: 1.21 
- 12.43). In this study, female patients were 
found to be more adhere to treatment. Probably 
because most of them were housewives, they 
could manage time very well between their 
activity and needs of treatment, unlike men who 
have lost a lot of time due to high mobility of 
work and outside activities. In addition, smoking 
habits, alcohol consumption and using drugs 
(IDUs) tend to be lower in women than men. All 
of these factors might influence the success of 
TB treatment in HIV patients 15,23,24.
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 Multivariate analysis showed that patients 
with CD4 counts> 200 had a chance of 15.80 
(95% CI: 3.18 to 78.64) more succeed than 
patients with CD4 counts <50. Similar thing 
appeared on patients with CD4 counts between 
101-200, they were 5 times more likely to 
be successful whereas patients with CD4 cell 
counts of 50-100 also has a tendency to succeed 
eventhough not statistically significant. Low 
CD4 count was identically associated with more 
advanced disease, heavier immunodeficient and 
more susceptibel against other infections, hence 
these patients were less likely to be successful 
in TB and ARV treatment15,25,26.
The severity of anemia might indicate an 
increased in disease progression especially in 
chronic diseases such as TB and HIV. Moreover, 
the degree of anemia also determined patients 
prognosis and presented the progress of the 
given therapy, therefore, the anemic conditions 
need to be strictly supervised27,28. HIV-TB 
patients without anemia were more likely to 
succeed in treatment of TB than patients with 
anemia (aOR 2.00 95% CI: 1.22 - 3.26). Patients 
with severe anemia at the start of treatment 
could not survive longer. On the other hand, the 
less severe of anemia in patients, the lower the 
risk of death and failure of treatment29. 
 Previous studies proved that there was a 
significant relationship between adherence and 
compliance during treatment with the cure and 
TB treatment success30,31,32,33. Similar result was 
found in this study. Adhered patients were nearly 
14 times more likely to succeed than unadhered 
patients. Regularity in treatment will increase 
the chances of recovering, reducing the risk of 
failure and relapse, prevent TB transmission 
and reduce the risk of MDR-TB in co-infected 
patients18,20,31,34.
CONCLUSION
Being female, CD4 count of 101-200, 
CD4 count> 200, unanemia and more adhere 
to TB treatment determined the successful 
of TB treatment among HIV-TB patients. 
Implementation of TB/HIV collaborative program 
and DOTS strategy have increased the success 
rate of TB treatment at H. Adam Malik General 
Hospital.
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